Journal of Capital Medical University ›› 2021, Vol. 42 ›› Issue (4): 635-641.doi: 10.3969/j.issn.1006-7795.2021.04.020

• Clinical Research • Previous Articles     Next Articles

Validity and reliability of the Chinese version ofWorld Health Organization Quality of Life-BREF among patients with end-stage renal disease

Liu Yijun1, Lin Xiangying1*, Zhang Yan2   

  1. 1. Yantai Institute of China Agricultural University, Yantai 264003, Shandong Province, China;
    2. Department of Nephrology, Yantai Yuhuangding Hospital,Yantai 264000, Shandong Province, China
  • Received:2021-04-06 Online:2021-08-21 Published:2021-07-29
  • Contact: * E-mail:xiangyinglin@163.com
  • Supported by:
    National Innovation and Entrepreneurship Training Program for College Students(202110019090).

Abstract: Objective To verify the reliability and validity of the Chinese version of the World Health Organization Quality of Life-BREF(WHOQOL-BREF) among patients with end-stage renal disease. Methods A stratified proportional sampling method was used to select 55 patients with end-stage renal disease in a grade a class Ⅲ-hospital Y in Yantai City, Shandong Province. Results WHOQOL-BREF had a nice internal consistency. The content validity was conducted by the expert evaluation method and the correlation coefficient method, having a good content validity. End-stage renal disease(ESRD) patients with different subsistence allowances, dialysis age, current personal monthly income and household monthly income before illness had different scores in the area of surrounding environment (P<0.05). It meant that the scale hada passable discriminated validity. Conclusion The Chinese version of WHOQOL-BREF is suitable for evaluating the quality of life of patients with end-stage renal disease and has good reliability and validity.

Key words: end-stage renal disease, the World Health Organization Quality of Life-BREF, reliability, validity

CLC Number: